Mikhail Blagosklonny
Mikhail Blagosklonny
Professor of Oncology, RPCI and Editor-in-Chief, Oncotarget
Verified email at oncotarget.com
Cited by
Cited by
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G Kroemer, L Galluzzi, P Vandenabeele, J Abrams, ES Alnemri, ...
Cell death & differentiation 16 (1), 3-11, 2009
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L Galluzzi, I Vitale, JM Abrams, ES Alnemri, EH Baehrecke, ...
Cell Death & Differentiation 19 (1), 107-120, 2012
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
Stabilization of wild-type p53 by hypoxia-inducible factor 1α
WG An, M Kanekal, MC Simon, E Maltepe, MV Blagosklonny, LM Neckers
Nature 392 (6674), 405-408, 1998
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death
G Kroemer, WS El-Deiry, P Golstein, ME Peter, D Vaux, P Vandenabeele, ...
Cell death and differentiation 12 (12), 1463-1467, 2005
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L Galluzzi, JM Bravo-San Pedro, I Vitale, SA Aaronson, JM Abrams, ...
Cell Death & Differentiation 22 (1), 58-73, 2015
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ...
Cell Death & Differentiation 16 (8), 1093-1107, 2009
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms
V Sandor, S Bakke, RW Robey, MH Kang, MV Blagosklonny, J Bender, ...
Clinical Cancer Research 8 (3), 718-728, 2002
Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association
TW Schulte, MV Blagosklonny, C Ingui, L Neckers
Journal of Biological Chemistry 270 (41), 24585-24588, 1995
The restriction point of the cell cycle
MV Blagosklonny, AB Pardee
Cell cycle 1 (2), 102-109, 2002
Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway
MV Blagosklonny, T Schulte, P Nguyen, J Trepel, LM Neckers
Cancer research 56 (8), 1851-1854, 1996
Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death
MV Blagosklonny, P Giannakakou, WS El-Deiry, DGI Kingston, PI Higgs, ...
Cancer research 57 (1), 130-135, 1997
Molecular effects of paclitaxel: myths and reality (a critical review)
MV Blagosklonny, T Fojo
International journal of cancer 83 (2), 151-156, 1999
p53 is associated with cellular microtubules and is transported to the nucleus by dynein
P Giannakakou, DL Sackett, Y Ward, KR Webster, MV Blagosklonny, ...
Nature cell biology 2 (10), 709-717, 2000
Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90
MV Blagosklonny, J Toretsky, S Bohen, L Neckers
Proceedings of the National Academy of Sciences 93 (16), 8379-8383, 1996
Rapamycin decelerates cellular senescence
ZN Demidenko, SG Zubova, EI Bukreeva, VA Pospelov, TV Pospelova, ...
Cell cycle 8 (12), 1888-1895, 2009
Aging: Ros or tor
MV Blagosklonny
Cell cycle 7 (21), 3344-3354, 2008
p53 inhibits hypoxia-inducible factor-stimulated transcription
MV Blagosklonny, WG An, LY Romanova, J Trepel, T Fojo, L Neckers
Journal of Biological Chemistry 273 (20), 11995-11998, 1998
P21-dependent G 1 arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228
V Sandor, A Senderowicz, S Mertins, D Sackett, E Sausville, ...
British journal of cancer 83 (6), 817-825, 2000
Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition
MV Blagosklonny
Cell cycle 5 (18), 2087-2102, 2006
The system can't perform the operation now. Try again later.
Articles 1–20